ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kil Dong Kim
Young Sam Kim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suk Park, M.
Right arrow Articles by Kyu Kim, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suk Park, M.
Right arrow Articles by Kyu Kim, S.
Related Collections
Right arrow Mediastinum
Right arrowRelated Article

Ann Thorac Surg 2004;78:992-997
© 2004 The Society of Thoracic Surgeons

Original article: general thoracic

Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification

Moo Suk Park, MDa, Kyung Young Chung, MD, PhDb,d, Kil Dong Kim, MD, PhDb,d, Woo Ick Yang, MD, PhDc, Jae Ho Chung, MDa, Young Sam Kim, MDa,d, Joon Chang, MD, PhDa,d, Joo Hang Kim, MD, PhDa,d, Sung Kyu Kim, MD, PhDa,d,*, Se Kyu Kim, MD, PhDa,d,e,f

a Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
b Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, South Korea
c Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea
d The Institute of Chest DiseasesYonsei University College of Medicine, Seoul, South Korea
e Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, South Korea
f Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, South Korea

Accepted for publication March 30, 2004.

* Address reprint requests to Dr Se Kyu Kim, Department of Internal Medicine, Yonsei University College of Medicine, CPO Box 8044, Seoul, South Korea
sekyukim{at}yumc.yonsei.ac.kr

BACKGROUND: The aim of this study was to document the prognosis of thymic epithelial tumors (TETs) according to new the World Health Organization (WHO) classification.

METHODS: We retrospectively reviewed 150 patients with TETs that were confirmed pathologically during 11 years (from 1992 to 2002) in Severance Hospital, Seoul, Korea.

RESULTS: TETs were classified as type A, AB, B1, B2, B3, or C, tumors and these represented 7 (4.7%), 26 (17.3%), 13 (8.7%), 45 (30.0%), 26 (17.3%), and 33 (22.0%) cases, and the 5-year survival rates were 100%, 93%, 89%, 82%, 71%, and 23%, respectively. Their Masaoka stages were I, II, III, IVa, and IVb, with 53 (35.3%), 39 (26.0%), 20 (13.3%), 22 (14.7%), and 16 (10.7%) cases. Tumor invasiveness, recurrence, completeness of resection, and tumor-related death were more frequent in types AB, B2, B3, and C than in types A and B1. Multivariate analysis showed that Masaoka stage (p < 0.001) and the WHO classification (p = 0.019) were significant independent prognostic factors.

CONCLUSIONS: The WHO classification is associated with tumor invasiveness, recurrence, completeness of resection, and tumor-related death, and has good correlation with Masaoka stage. The WHO histologic subtypes are an independently significant prognostic factor with respect to survival in our multivariate analysis. Types AB, B2, B3, and C showed invasive behaviors and R1 or R2 resections were frequently performed. Postoperative adjuvant radiotherapy was effective, but long-term follow-up is recommended because of decreased survival after 5 years following operation. The WHO classification may be helpful in clinical practice for the assessment and treatment of TET patients.


Related Article

Invited commentary
Juan Rosai
Ann. Thorac. Surg. 2004 78: 997-998. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JCOHome page
E. O. Gamboa, V. Sawhney, R. S. Lanoy, N. A. Haller, A. T. Powell, and S. V. Hazra
Widespread Metastases After Resection of Noninvasive Thymoma
J. Clin. Oncol., April 1, 2008; 26(10): 1752 - 1755.
[Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S Suster
Diagnosis of thymoma
J. Clin. Pathol., December 1, 2006; 59(12): 1238 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. F. Riedel and W. R. Burfeind Jr
Thymoma: Benign Appearance, Malignant Potential
Oncologist, September 1, 2006; 11(8): 887 - 894.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. C. Detterbeck
Clinical Value of the WHO Classification System of Thymoma
Ann. Thorac. Surg., June 1, 2006; 81(6): 2328 - 2334.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. D. Wright, J. C. Wain, D. R. Wong, D. M. Donahue, H. A. Gaissert, H. C. Grillo, and D. J. Mathisen
Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1413 - 1421.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.